AbbVie to Pay $21 Billion for Pharmacyclics, Maker of a Promising Cancer Drug. Pharmacyclics, Incorporated, de la Merced, Michael J, Pollack, Andrew, AbbVie Inc, Drugs (Pharmaceuticals), Mergers, Acquisitions and Divestitures, Cancer, Johnson & Johnson